NDC 63304-515 - Amoxicillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63304-515
- Package NDCs from labels
- 63304-515-30, 63304-515-01, 63304-515-04
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2012-10-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amoxicillin - Physicians Total Care, Inc. | Physicians Total Care, Inc. | 2012-10-19 | HUMAN PRESCRIPTION DRUG LABEL |
| AMOXICILLIN - Ranbaxy Pharmaceutical Inc. | Ranbaxy Pharmaceutical Inc. | 2008-05-19 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63304-515-01 | AMOXICILLIN | 100 in 1 BOTTLE | TABLET, CHEWABLE | 100 | 1 | |
| 63304-515-04 | AMOXICILLIN | 250 in 1 BOTTLE | TABLET, CHEWABLE | 250 | 1 | |
| 63304-515-30 | AMOXICILLIN | 30 in 1 BOTTLE | TABLET, CHEWABLE | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63304-515 | AMOXICILLIN (AMOXICILLIN) CAPSULE AMOXICILLIN (AMOXICILLIN) TABLET, FILM COATED AMOXICILLIN (AMOXICILLIN) TABLET, CHEWABLE AMOXICILLIN (AMOXICILLIN) SUSPENSION [RANBAXY PHARMACEUTICAL INC.] | 1 | 3 package rows | 20080602_649d285c-8fcb-48dd-aa5e-2f34128102f5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63304-515-01 | EA - Each | 63304-515 | 646fd49d-eaa0-4648-b478-a2dba7f29801 | 1 | 2015-10-02 |
| 63304-515-04 | EA - Each | 63304-515 | 2c533ba4-0be6-49c3-9704-987a06e56b83 | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Bryant Ranch Prepack | dfdde253-44b8-4074-b759-7bc40ea26cf9 | 2026-03-12 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | American Health Packaging | 4966a3f2-eed2-4081-ba88-310a3d1964b4 | 2026-03-06 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | fc31a5df-aa1c-4b0f-8c64-a14236df4a02 | 2026-03-05 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | afef7c71-2d19-41ed-9213-b32ccc1bf1d3 | 2026-03-04 | Warnings, Adverse reactions | 313850 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 4b23e6f5-9287-4c01-b795-b8c538833039 | 2026-03-04 | Warnings, Adverse reactions | 308194 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 720ee5cf-1962-423b-ac81-6dd4f02b9206 | 2026-03-04 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | c0e333d9-164d-4196-b5f5-929993d1c3c2 | 2026-03-04 | Warnings, Adverse reactions | 308189 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Phamraceuticals Inc. | 47424822-14a1-48e0-a62d-df34fe685726 | 2026-03-04 | Warnings, Adverse reactions | 308191 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 573fcf4a-2b87-45d9-ac73-e1dec4fbc28b | 2026-03-04 | Warnings, Adverse reactions | 313850 308189 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals, Inc. | 22a387bd-92ce-4ebc-b475-20d7750a2507 | 2026-03-04 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 8dfbaa75-87ba-4a6b-a2db-176441a842af | 2026-03-04 | Warnings, Adverse reactions | 308189 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 1b8a6312-ae47-45fb-ba5e-eedbc176afa0 | 2026-03-03 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | d6a33b28-f520-4a4c-b553-0ebd00558345 | 2026-03-03 | Warnings, Adverse reactions | 308182 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | d23b6952-5e4c-4103-9fe0-a916b1e2e1b9 | 2026-03-03 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 618953a3-0256-42ce-9155-d35325f017aa | 2026-03-02 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 56fb634c-3725-4d0a-8f20-584652a1d99f | 2026-03-02 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Hikma Pharmaceuticals USA Inc. | 4fb7837e-964c-4d38-a3a5-b384b1bd6e08 | 2026-03-01 | Warnings, Adverse reactions | 308191 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 30446852-9a54-4d16-ba12-56ffd0149985 | 2026-02-27 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | d213685c-5e67-4130-b00b-7626685dfa16 | 2026-02-26 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 6a078e7d-f942-4185-a131-50215d8e0a1e | 2026-02-25 | Warnings, Adverse reactions | 804826J2HU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.